Research Break-through
The scientific community discovered the biological properties of rare ginsenosides
about 30 years ago. In recent years, continued in-depth studies proved that rare ginsenosides
play a positive role in enhancing health and improving life quality.

Research dilemma #1

People have realized the great value of rare ginsenosides for a long time, but rare ginsenosides are very difficult to obtain for two main reasons: 1) Rare ginsenoside contents in Araliaceae ginseng species are almost undetectable, even after heat processing, the extraction rate of ginsenosides reaches only 1/100,000 - 1/10,000; 2) Rare ginsenosides cannot be made in large quantities through industrialized preparations, due to the high cost of raw materials and the immaturity of preparation methodologies.

Research dilemma #2

Ginsenosides in their natural-occurring forms (prototype ginsenosides R1, Ra1, Ra2, Ra3, Rb1, Rb2, Rb3, Rc, Rd, Rg1 etc.), cannot be directly absorbed by the human body. They must first undergo proper gastrointestinal metabolisms and be converted into rare ginsenosides before effective absorption could take place.

Research dilemma #3


rare ginsenosides are neither water-soluble nor lipid-soluble, and traditional dispersion technology of preparation cannot achieve optimal absorption and utilization.
Four core technologies owned by
Canada Royal Enoch Phytomedicine Ltd.
Canada Royal Enoch Phytomedicine Ltd.,engaged in phytomedicine research for over 10 years,eventually
conquered the difficulties in extraction, processing, transformation, and formulation of ginseng extracts
and invented 4 core technologies.Our GMP standard manufacturing workshop, located in Vancouver, Canada, is capable of industrialized production.
Our products have already benefited users from North America and Europe.

Raw material processing technology

By employing unique steam explosion technology, a new type of American red ginseng, which contains various prototype ginsenosides and rare ginsenosides, could be successfully obtained.

Ginsenosides extraction technology

By employing new molecular structure directional modification technology, prototype ginsenosides and rare ginsenosides are separately extracted.

In vitro biotransformation technology

By employing unique highly directional sugar degradation and dehydration transformation technology, prototype ginsenosides could be successfully transformed into rare ginsenosides.

Drug preparation technology

By employing nano solid dispersions and microcapsule technology, multiple rare ginsenosides are formulated into water-soluble Redsenol capsules and Redsenol-DAG sublingual pills. They act together synergistically to achieve an augmented effect.
3800 Wesbrook Mall Vancouver,
BC V6S 2L9 Canada
1-604-638-9936
global@enophyto.com
redsenolhealth
Copyright © 2019, Canada Royal Enoch Phytomedicine Ltd. All rights reserved.